跳至主要内容
临床试验/DRKS00018934
DRKS00018934已完成3 期

Remote Ischemic Preconditioning (RIPC) versus sham-control for prevention of anastomotic leakage after resection for Esophageal cancer: a prospective, randomized controlled, triple-blind, clinical phase III monocenter trial - RIPE

Medizinische Fakultät Mannheim0 个研究点目标入组 55 人开始时间: 2019年10月28日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Persons meeting the following criteria may be included in the study:
  • Planned elective esophagus resection for esophageal cancer
  • Signed informed consent
  • Age =18 years

排除标准

  • Persons meeting any of the following criteria cannot be included in the study:
  • Patients not able to give informed consent
  • Patients presenting with the following contraindications to the study intervention (RIPC): arterial occlusive disease (AOD), infections or wounds on the upper extremity, poorly controlled diabetes mellitus, or deep vein thrombosis of the upper extremity

研究者

相似试验